Премини към основното съдържание
Home
language-selector-globe Bulgaria | bg
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Bulgaria
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • За нас 
      • Новартис в България 
      • Нашата стратегия 
        • Иновативни лекарства 
      • Хора и Култура 
      • Контакти 
      За нас За нас
    • Пациенти и болногледачи 
      • Аз само да попитам: твоят здравен консултант 
      • Ангажиментът на Новартис към пациентите и лицата, които се грижат за тях 
      • Съобщаване на нежелани реакции 
      • Аз само да попитам: твоят здравен портал 
      Пациенти и болногледачи Пациенти и болногледачи
    • Здравни специалисти 
      • Материали за здравни специалисти 
      • Новартис проекти 
      • Съобщаване на нежелани реакции 
      • Клинични проучвания на Новартис 
      Здравни специалисти Здравни специалисти
    • ESG 
      • Етика, Риск и Законосъобразност 
      • Разширяване на достъпа до здравеопазване 
      • Опазване на природата 
      • Световно здраве 
      • Етично поведение 
        • Етичен кодекс 
        • SpeakUp 
      Околна среда, социални и правни въпроси ESG
    • Новини 
      • Медийни контакти 
      • Новини 
      Новини Новини
    • Кариера 
      • Търсене на кариера 
      • Награди и признание 
      Кариера Кариера
    • Коронавирус 
      Коронавирус Коронавирус
    Новартис България Начало
  1. Начало
  2. Кариера
  3. Търсене на кариера
  • Sort by Sort ascending
  • Длъжност
  • Място Sort descending
  • Местоположение
  • дивизия
  • Бизнес
  • Functional Area
  • Дата
Длъжност Място Sort descending Местоположение дивизия Бизнес Functional Area Дата
Treasury & Cash Management Team Lead Selangor Malaysia Finance CTS Audit & Finance Авг. 12, 2024
Hire to Retire Services Specialist Selangor Malaysia People & Organization CTS Human Resources Авг. 19, 2024
R2R Senior Specialist - GL & Reporting Selangor Malaysia Finance CTS Audit & Finance Авг. 19, 2024
FRA Technical Accounting & Special Projects APMA Selangor Malaysia Operations CTS Audit & Finance Авг. 22, 2024
Ethics, Risk & Compliance Manager Selangor Malaysia Ethics Risk & Compliance Innovative Medicines Legal & Intellectual Property & Compl. Авг. 22, 2024
Sr Specialist DDIT IM JP & APMA Soln Int Selangor Malaysia Operations CTS Technology Transformation Авг. 22, 2024
Hire to Retire Services Specialist Selangor Malaysia People & Organization CTS Human Resources Май 19, 2024
P2P & T&E Specialist (Japanese speaker) Selangor Malaysia Finance CTS Audit & Finance Юни 05, 2024
P2P & T&E Business Partner (Japanese speaker) Selangor Malaysia Finance CTS Audit & Finance Юни 12, 2024
R2R Senior Specialist GL & Reporting Selangor Malaysia Finance CTS Audit & Finance Юни 13, 2024
Regional Sourcing Manager APAC-Indirect (Japanese Speaker) Selangor Malaysia Operations CTS Procurement Юли 22, 2024
Project Manager Selangor Malaysia Operations CTS Technology Transformation Септ. 03, 2024
R2R Specialist - Inventory Selangor Malaysia Finance CTS Audit & Finance Юли 28, 2024
P2P & T&E Specialist (Arabic Speaker) Selangor Malaysia Finance CTS Audit & Finance Юли 05, 2024
ERP Assurance Senior Consultant Selangor Malaysia Operations CTS Audit & Finance Юли 17, 2024
Engagement Services Senior Expert (Japanese Speaker) Selangor Malaysia People & Organization CTS Human Resources Септ. 04, 2024
Hire to Retire Services Expert Selangor Malaysia People & Organization CTS Human Resources Септ. 05, 2024
Manufacturing Systems Expert Selangor Malaysia Operations Innovative Medicines Technical Operations Септ. 05, 2024
P&R Manager Seoul South Korea International Innovative Medicines Market Access Септ. 27, 2024
Patient Support Program Lead Seoul South Korea International Innovative Medicines Marketing Септ. 24, 2024
Senior Patient Safety Specialist Seoul South Korea Development Innovative Medicines Research & Development Окт. 20, 2024
RLT Customer Service Coordinator Seoul South Korea International Innovative Medicines Sales Авг. 27, 2024
Renal Medical Lead Seoul South Korea International Innovative Medicines Research & Development Септ. 01, 2024
ASCVD Brand Manager Seoul South Korea International Innovative Medicines Marketing Септ. 03, 2024
Sr. Medical Science Liaison, ASCVD Seoul South Korea International Innovative Medicines Research & Development Септ. 05, 2024
Head DPDAI China Shanghai (Shanghai) China Ethics Risk & Compliance Innovative Medicines Legal & Intellectual Property & Compl. Окт. 14, 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales Окт. 09, 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales Окт. 23, 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales Окт. 25, 2024
Senior Brand Manager Shanghai (Shanghai) China International Innovative Medicines Marketing Апр. 16, 2024
MSL Manager, RLT Shanghai (Shanghai) China International Innovative Medicines Research & Development Апр. 18, 2024
(高级)地区经理 Shanghai (Shanghai) China International Innovative Medicines Sales Юни 21, 2024
Sr. Manager DDIT GF Sol.Del. China Shanghai (Shanghai) China Operations CTS Technology Transformation Септ. 03, 2024
Senior Brand Manager Shanghai (Shanghai) China International Innovative Medicines Marketing Апр. 29, 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales Окт. 23, 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales Окт. 25, 2024
(高级)地区经理 Shanghai (Shanghai) China International Innovative Medicines Sales Юни 21, 2024
(高级)地区经理 Shanghai (Shanghai) China International Innovative Medicines Sales Юни 21, 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales Окт. 25, 2024
(高级)大区经理 Shanghai (Shanghai) China International Innovative Medicines Sales Окт. 17, 2024
Medical Advisor, Ophtha Shanghai (Shanghai) China International Innovative Medicines Research & Development Окт. 18, 2024
Medical Advisor, HEMA Shanghai (Shanghai) China International Innovative Medicines Research & Development Окт. 18, 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales Окт. 23, 2024
Study Start-Up Lead Shanghai (Shanghai) China Development Innovative Medicines Research & Development Окт. 22, 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales Окт. 23, 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales Окт. 25, 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales Окт. 23, 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales Окт. 25, 2024
(高级)地区经理 Shanghai (Shanghai) China International Innovative Medicines Sales Юни 21, 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales Окт. 23, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • …
  • 42
  • › Next page

Новартис България

Навигация
  • Пациенти и болногледачи
  • Здравни специалисти
  • ESG
  • Новини
  • Кариера
Медиен център
  • Архив
  • Новини
Нашето портфолио
  • Клинични проекти на Новартис
Други сайтове на Новартис
  • Глобален сайт
Footer Bottom
© 2024 Новартис АГ
  • Политика за поверителност
  • Условия на ползване
  • Достъп от мрежата
  • Настройки за бисквитки
  • Навигация на сайта
Директория на сайта на Новартис
Тази страница е предназначена за обществеността в България